Cargando…

Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis

INTRODUCTION: Moderate hypofractionated (HF) radiotherapy is becoming the new standard in radiotherapy for prostate cancer patients. It is established as safe, but it might be associated with increased acute toxicity levels. We conducted a systematic review on moderate HF to establish acute toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinzabakira, F., Brand, V., Heemsbergen, W.D., Incrocci, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040508/ https://www.ncbi.nlm.nih.gov/pubmed/36992969 http://dx.doi.org/10.1016/j.ctro.2023.100612

Ejemplares similares

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Association between incidental dose outside the prostate and tumor control after modern image-guided radiotherapy
por: Witte, Marnix, et al.
Publicado: (2021)

Automated Radiotherapy Planning for Patient-Specific Exploration of the Trade-Off Between Tumor Dose Coverage and Predicted Radiation-Induced Toxicity—A Proof of Principle Study for Prostate Cancer
por: Bijman, Rik, et al.
Publicado: (2020)

Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer
por: Narwariya, Abhinav, et al.
Publicado: (2022)

Acute toxicities after extremely hypofractionated radiotherapy for prostate cancer: lessons from HYPO-RT-PC and PACE-B
por: Juarez, Jesus E., et al.
Publicado: (2020)

Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost–utility analysis alongside a randomized HYPO-RT-PC trial
por: Sun, Sun, et al.
Publicado: (2022)

The Risk of Second Primary Cancers in Prostate Cancer Survivors Treated in the Modern Radiotherapy Era
por: Jahreiß, Marie-Christina, et al.
Publicado: (2020)

Model-Supported Radiotherapy Personalization: In silico Test of Hyper- and Hypo-Fractionation Effects
por: Belfatto, Antonella, et al.
Publicado: (2018)

Investigation of irradiated volume in linac-based brain hypo-fractionated stereotactic radiotherapy
por: Ruschin, Mark, et al.
Publicado: (2017)

Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
por: Zach, Leor, et al.
Publicado: (2021)

A prospective randomized comparative study to evaluate the effect of palliative hypo-fractionated radiotherapy with concurrent chemotherapy versus hypo-fractionated radiotherapy alone in advanced and unresectable head and neck cancer with no metastasis
por: Uttam, Aditya Kumar, et al.
Publicado: (2023)

A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receiving high dose rate brachytherapy combined with hypo-fractionated radiotherapy or hypo-fractionated radiotherapy alone for the treatment of localised prostate cancer
por: Crowther, Karen, et al.
Publicado: (2019)

Change in prostate volume during extreme hypo-fractionation analysed with MRI
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2014)

Radiotherapy for prostate cancer and sexual health
por: Incrocci, Luca
Publicado: (2015)

Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy
por: Mushonga, Melinda, et al.
Publicado: (2023)

AB007. Testosterone and radiotherapy for prostate cancer
por: Incrocci, Luca
Publicado: (2015)

Radiotherapy Practice for Treatment of Bone Metastasis in Ethiopia
por: Rick, Tara J., et al.
Publicado: (2020)

Palliative Hypo-fractionated Radiotherapy in Locally Advanced Head and Neck Cancer with Fixed Neck Nodes
por: Paliwal, Rajan, et al.
Publicado: (2012)

Re-irradiation with hypo-fractionated stereotactic robotic radiotherapy for salvage in adult patients with brainstem glioma
por: Susheela, Sridhar P, et al.
Publicado: (2013)

Challenges and opportunities for implementing hypofractionated radiotherapy in Africa: lessons from the HypoAfrica clinical trial
por: Olatunji, Elizabeth, et al.
Publicado: (2023)

Variation of Tumor Volume During Moderate Hypo-Fractionated Stereotactic Body Radiation Therapy for Lung Cancer
por: Nishimura, Keiichiro, et al.
Publicado: (2021)

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
por: Li, Ning, et al.
Publicado: (2018)

Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2017)

Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases
por: Yang, Siran, et al.
Publicado: (2023)

Systematic Review of the Relationship between Acute and Late Gastrointestinal Toxicity after Radiotherapy for Prostate Cancer
por: Peach, Matthew Sean, et al.
Publicado: (2015)

Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
por: Roger, Anissa, et al.
Publicado: (2018)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
por: Martinage, Geoffrey, et al.
Publicado: (2019)

Moderately hypo-fractionated radiotherapy combined with S-1 in inoperable locally advanced esophageal squamous cell carcinoma: A prospective, single-arm phase II study (GASTO-1045)
por: Zhou, Rui, et al.
Publicado: (2023)

Normo- or Hypo-Fractionated Photon or Proton Radiotherapy in the Management of Locally Advanced Unresectable Pancreatic Cancer: A Systematic Review
por: Elkhamisy, Sally A., et al.
Publicado: (2023)

Effect of definitive hypo-fractionated radiotherapy concurrent with weekly cisplatin in locally advanced squamous cell carcinoma of the head and neck
por: Abdelhafiz, Nora, et al.
Publicado: (2023)

Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy
por: Kerns, Sarah L, et al.
Publicado: (2019)

Assessment of Radiation-Induced Bladder and Bowel Cancer Risks after Conventionally and Hypo-Fractionated Radiotherapy for the Preoperative Management of Rectal Carcinoma
por: Matsali, Ekaterini, et al.
Publicado: (2022)

Editorial Comment: Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
por: Lott, Felipe
Publicado: (2020)

Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial
por: Jiang, Ping, et al.
Publicado: (2017)

Radioresistance Mechanisms in Prostate Cancer Cell Lines Surviving Ultra-Hypo-Fractionated EBRT: Implications and Possible Clinical Applications
por: Sideri, Silvia, et al.
Publicado: (2022)

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer
por: Kerns, Sarah L., et al.
Publicado: (2016)

Prostate Cancer Radiotherapy: Increased Biochemical Control and Late Toxicity in Men With Medication Allergies
por: Turchan, William Tyler, et al.
Publicado: (2020)

Predicting Radiotherapy Impact on Late Bladder Toxicity in Prostate Cancer Patients: An Observational Study
por: Catucci, Francesco, et al.
Publicado: (2021)

Moderate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trials
por: Yin, Zhenzhen, et al.
Publicado: (2019)

A priori prediction of local failure in brain metastasis after hypo-fractionated stereotactic radiotherapy using quantitative MRI and machine learning
por: Jaberipour, Majid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9nec29o4c61k3lkst35dkccjv7